HBEGF and ovarian cancer: qRT-PCR demonstrated that HBEGF expression in PBMCs from ovarian cancer patients was 9-fold higher than in healthy donors (Figure 2C), and flow cytometry confirmed that the monocyte population was positive for HB-EGF (Supplementary Figure S2).